401PEVEROLIMUS PLUS HORMONOTHERAPY (HT) INDUCES SURVIVAL GAIN IN LATE METASTATIC BREAST CANCER (MBC) AFTER PROGRESSION: COULD THIS LINE BE BETTER THAN A LATE NEW CHEMOTHERAPY (CT) LINE?
Pouget, M., Planchat, E., Abrial, C., van Praagh, I., Arbre, M., Kwiatkowski, F., Dubray-Longeras, P., Devaud, H., Wang-Lopez, Q., Mahammedi, H., Durando, X., Chollet, P., Mouret-Reynier, M.Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu329.50
Date:
September, 2014
File:
PDF, 64 KB
2014
File converter
More search results
More benefits 
